{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:05:53Z","timestamp":1790143553689,"version":"4.0.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI18C2383"],"award-info":[{"award-number":["HI18C2383"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HL19C0015"],"award-info":[{"award-number":["HL19C0015"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schizophr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the present study, various outcomes over 3-year period in patients with early stage psychosis including remission, recovery, relapse and medication adherence were investigated. Predictor for full recovery at year 3 was also examined. Three-year follow-up data in 534 patients with schizophrenia spectrum disorders (SSD) and psychotic disorder not otherwise specified (PNOS) were examined for overall outcome trajectories. The data of completers at year 3 (<jats:italic>n<\/jats:italic>\u2009=\u2009157) were used to identify predictors for recovery using logistic regression. The rates of symptomatic remission and full recovery at 6-, 12-, 24-, and 36-month follow-up were 76.10, 69.20, 79.50, and 79.10%, and 22.80, 26.40, 28.60, and 39.60%, respectively. The rates of drop-out and relapse at 6-, 12-, 24-, and 36-month follow-up were 25.4, 29.5, 38.6, and 51.1%, and 3.7, 8.9, 19.0, and 38.9%, respectively. The rates of good adherence and prescription of Long-Acting Injectable Antipsychotics (LAIA) at 6-, 12-, 24- and 36-month follow-up were 87.8, 88.0, 91.9, and 93.9%, and 18.3, 21.7, 22.0, and 25.5%, respectively. Significant predictors for full recovery were duration of untreated psychosis (DUP), family intimacy and physical activity. We observed similar or better results on remission, recovery, and relapse rates compared to other previous studies. Effective psychosocial intervention should be provided to shorten the gap between remission and recovery rates and to address DUP, family issues, and exercise to enhance recovery.<\/jats:p>","DOI":"10.1038\/s41537-022-00301-4","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T07:02:49Z","timestamp":1666854169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Three-year outcomes and predictors for full recovery in patients with early-stage psychosis"],"prefix":"10.1038","volume":"8","author":[{"given":"Ling","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Zahra","family":"Rami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Mi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6739-2163","authenticated-orcid":false,"given":"Sung-Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bong Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Je-Chun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hee","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi Hyun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euitae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Chul","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"301_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/schbul\/sbaa081","volume":"47","author":"SN Avery","year":"2021","unstructured":"Avery, S. N. et al. Relational memory in the early stage of psychosis: a 2-year follow-up study. Schizophr. Bull 47, 75\u201386 (2021).","journal-title":"Schizophr. Bull"},{"key":"301_CR2","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1176\/appi.ajp.158.11.1835","volume":"158","author":"M Gitlin","year":"2001","unstructured":"Gitlin, M. et al. Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. Am. J. Psychiatry 158, 1835\u20131842 (2001).","journal-title":"Am. J. Psychiatry"},{"key":"301_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neulet.2012.09.033","volume":"531","author":"W Guo","year":"2012","unstructured":"Guo, W. et al. Right lateralized white matter abnormalities in first-episode, drug-naive paranoid schizophrenia. Neurosci. Lett. 531, 5\u20139 (2012).","journal-title":"Neurosci. Lett."},{"key":"301_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0366-5","volume":"9","author":"E Martinuzzi","year":"2019","unstructured":"Martinuzzi, E. et al. Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study. Transl. Psychiatry 9, 20 (2019).","journal-title":"Transl. Psychiatry"},{"key":"301_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/jhg.2012.140","volume":"58","author":"M Nishioka","year":"2013","unstructured":"Nishioka, M. et al. Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia. J. Hum. Genet. 58, 91\u201397 (2013).","journal-title":"J. Hum. Genet."},{"key":"301_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1176\/appi.ajp.2015.15050632","volume":"173","author":"JM Kane","year":"2016","unstructured":"Kane, J. M. et al. Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program. Am. J. Psychiatry 173, 362\u2013372 (2016).","journal-title":"Am. J. Psychiatry"},{"key":"301_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1017\/S003329171500210X","volume":"46","author":"UK Haukvik","year":"2016","unstructured":"Haukvik, U. K. et al. No progressive brain changes during a 1-year follow-up of patients with first-episode psychosis. Psychol. Med. 46, 589\u2013598 (2016).","journal-title":"Psychol. Med"},{"key":"301_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/oxfordjournals.schbul.a006986","volume":"29","author":"TS Stroup","year":"2003","unstructured":"Stroup, T. S. et al. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr. Bull 29, 15\u201331 (2003).","journal-title":"Schizophr. Bull"},{"key":"301_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/10673229.2012.747804","volume":"20","author":"B AlAqeel","year":"2012","unstructured":"AlAqeel, B. & Margolese, H. C. Remission in schizophrenia: Critical and systematic review. Harv. Rev. Psychiatry 20, 281\u2013297 (2012).","journal-title":"Harv. Rev. Psychiatry"},{"key":"301_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1192\/bjp.bp.117.201475","volume":"211","author":"J Lally","year":"2017","unstructured":"Lally, J. et al. Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies. Br. J. Psychiatry 211, 350\u2013358 (2017).","journal-title":"Br. J. Psychiatry"},{"key":"301_CR11","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/schbul\/sbs130","volume":"39","author":"E J\u00e4\u00e4skel\u00e4inen","year":"2013","unstructured":"J\u00e4\u00e4skel\u00e4inen, E. et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr. Bull. 39, 1296\u20131306 (2013).","journal-title":"Schizophr. Bull."},{"key":"301_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1600-0447.2012.01883.x","volume":"126","author":"S Verma","year":"2012","unstructured":"Verma, S., Subramaniam, M., Abdin, E., Poon, L. Y. & Chong, S. A. Symptomatic and functional remission in patients with first-episode psychosis. Acta Psychiatr. Scand 126, 282\u2013289 (2012).","journal-title":"Acta Psychiatr. Scand"},{"key":"301_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.schres.2012.10.016","volume":"143","author":"WC Chang","year":"2013","unstructured":"Chang, W. C. et al. The concurrent and predictive validity of symptomatic remission criteria in first-episode schizophrenia. Schizophr. Res. 143, 107\u2013115 (2013).","journal-title":"Schizophr. Res."},{"key":"301_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/0004867411428015","volume":"46","author":"WC Chang","year":"2012","unstructured":"Chang, W. C. et al. Prediction of remission and recovery in young people presenting with first-episode psychosis in Hong Kong: a 3-year follow-up study. Aust. N. Z. J. Psychiatry 46, 100\u2013108 (2012).","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"301_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1176\/appi.ajp.161.3.473","volume":"161","author":"DG Robinson","year":"2004","unstructured":"Robinson, D. G., Woerner, M. G., McMeniman, M., Mendelowitz, A. & Bilder, R. M. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am. J. Psychiatry 161, 473\u2013479 (2004).","journal-title":"Am. J. Psychiatry"},{"key":"301_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.schres.2013.07.031","volume":"150","author":"SF Austin","year":"2013","unstructured":"Austin, S. F. et al. Predictors of recovery in first episode psychosis: the OPUS cohort at 10 year follow-up. Schizophr. Res. 150, 163\u2013168 (2013).","journal-title":"Schizophr. Res."},{"key":"301_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1177\/070674370805301005","volume":"53","author":"L Petersen","year":"2008","unstructured":"Petersen, L. et al. Predictors of remission and recovery in a first-episode schizophrenia spectrum disorder sample: 2-year follow-up of the OPUS trial. Can. J. Psychiatry 53, 660\u2013670 (2008).","journal-title":"Can. J. Psychiatry"},{"key":"301_CR18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/schbul\/sbn143","volume":"35","author":"L Wunderink","year":"2009","unstructured":"Wunderink, L., Sytema, S., Nienhuis, F. J. & Wiersma, D. Clinical recovery in first-episode psychosis. Schizophr. Bull. 35, 362\u2013369 (2009).","journal-title":"Schizophr. Bull."},{"key":"301_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41537-019-0091-y","volume":"6","author":"L Phahladira","year":"2020","unstructured":"Phahladira, L. et al. Early recovery in the first 24 months of treatment in first-episode schizophrenia-spectrum disorders. NPJ Schizophr. 6, 2 (2020).","journal-title":"NPJ Schizophr."},{"key":"301_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.schres.2010.10.013","volume":"125","author":"N Albert","year":"2011","unstructured":"Albert, N. et al. Predictors of recovery from psychosis Analyses of clinical and social factors associated with recovery among patients with first-episode psychosis after 5 years. Schizophr. Res. 125, 257\u2013266 (2011).","journal-title":"Schizophr. Res"},{"key":"301_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psychres.2010.11.010","volume":"188","author":"G Faber","year":"2011","unstructured":"Faber, G. et al. Neurocognition and recovery in first episode psychosis. Psychiatry Res. 188, 1\u20136 (2011).","journal-title":"Psychiatry Res"},{"key":"301_CR22","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.3390\/jcm10112474","volume":"10","author":"M Molina-Garc\u00eda","year":"2021","unstructured":"Molina-Garc\u00eda, M. et al. The role of premorbid IQ and age of onset as useful predictors of clinical, functional outcomes, and recovery of individuals with a first episode of psychosis. J. Clin. Med. 10, 2474 (2021).","journal-title":"J. Clin. Med."},{"key":"301_CR23","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1177\/0004867419827648","volume":"53","author":"D O\u2019Keeffe","year":"2019","unstructured":"O\u2019Keeffe, D. et al. The iHOPE-20 study: Relationships between and prospective predictors of remission, clinical recovery, personal recovery and resilience 20\u2009years on from a first episode psychosis. Aust. N. Z. J. Psychiatry 53, 1080\u20131092 (2019).","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"301_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/schbul\/sbi017","volume":"31","author":"K Rosen","year":"2005","unstructured":"Rosen, K. & Garety, P. Predicting recovery from schizophrenia: a retrospective comparison of characteristics at onset of people with single and multiple episodes. Schizophr. Bull. 31, 735\u2013750 (2005).","journal-title":"Schizophr. Bull."},{"key":"301_CR25","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/01.nmd.0000253783.32338.6e","volume":"195","author":"M Harrow","year":"2007","unstructured":"Harrow, M. & Jobe, T. H. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study. J. Nerv. Ment. Dis. 195, 406\u2013414 (2007).","journal-title":"J. Nerv. Ment. Dis."},{"key":"301_CR26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4088\/JCP.1107e27","volume":"68","author":"JM Kane","year":"2007","unstructured":"Kane, J. M. Treatment strategies to prevent relapse and encourage remission. J. Clin. Psychiatry 68, 27\u201330 (2007).","journal-title":"J. Clin. Psychiatry"},{"key":"301_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/hup.675","volume":"20","author":"M Taylor","year":"2005","unstructured":"Taylor, M. et al. Towards consensus in the long-term management of relapse prevention in schizophrenia. Hum. Psychopharmacol 20, 175\u2013181 (2005).","journal-title":"Hum. Psychopharmacol"},{"key":"301_CR28","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1192\/bjp.184.4.346","volume":"184","author":"S Almond","year":"2004","unstructured":"Almond, S., Knapp, M., Francois, C., Toumi, M. & Brugha, T. Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br. J. Psychiatry 184, 346\u2013351 (2004).","journal-title":"Br. J. Psychiatry"},{"key":"301_CR29","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1176\/appi.ajp.162.12.2220","volume":"162","author":"DL Penn","year":"2005","unstructured":"Penn, D. L., Waldheter, E. J., Perkins, D. O., Mueser, K. T. & Lieberman, J. A. Psychosocial treatment for first-episode psychosis: a research update. Am. J. Psychiatry 162, 2220\u20132232 (2005).","journal-title":"Am. J. Psychiatry"},{"key":"301_CR30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.schres.2012.05.007","volume":"139","author":"M Alvarez-Jimenez","year":"2012","unstructured":"Alvarez-Jimenez, M. et al. Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophr. Res. 139, 116\u2013128 (2012).","journal-title":"Schizophr. Res."},{"key":"301_CR31","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","volume":"371","author":"R Kahn","year":"2008","unstructured":"Kahn, R. et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomized clinical trial. Lancet 371, 1085\u20131097 (2008).","journal-title":"Lancet"},{"key":"301_CR32","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1176\/appi.ajp.2011.10081224","volume":"168","author":"J Tiihonen","year":"2011","unstructured":"Tiihonen, J. et al. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am. J. Psychiatry 168, 603\u2013609 (2011).","journal-title":"Am. J. Psychiatry"},{"key":"301_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.psychres.2013.05.003","volume":"210","author":"I Bonoldi","year":"2013","unstructured":"Bonoldi, I. et al. Prevalence of self-reported childhood abuse in psychosis: a meta-analysis of retrospective studies. Psychiatry Res. 210, 8\u201315 (2013).","journal-title":"Psychiatry Res."},{"key":"301_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.psychres.2010.07.011","volume":"185","author":"JC Badcock","year":"2011","unstructured":"Badcock, J. C. et al. The role of emotion regulation in auditory hallucinations. Psychiatry Res. 185, 303\u2013308 (2011).","journal-title":"Psychiatry Res"},{"key":"301_CR35","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/NMD.0b013e3181b3af20","volume":"197","author":"R Halari","year":"2009","unstructured":"Halari, R. et al. Rumination and negative symptoms in schizophrenia. J. Nerv. Ment. Dis. 197, 703\u2013706 (2009).","journal-title":"J. Nerv. Ment. Dis"},{"key":"301_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1017\/S1352465812000884","volume":"42","author":"N Thomas","year":"2014","unstructured":"Thomas, N. et al. Rumination, depressive symptoms and awareness of illness in schizophrenia. Behav. Cogn. Psychother. 42, 143\u2013155 (2014).","journal-title":"Behav. Cogn. Psychother."},{"key":"301_CR37","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. (Washington, DC, 1994)"},{"key":"301_CR38","first-page":"50","volume":"2","author":"WS Yoo","year":"2006","unstructured":"Yoo, W. S. et al. Validity of Korean version of the mini-international neuropsychiatric interview. Anxiety and Mood 2, 50\u201355 (2006).","journal-title":"Anxiety and Mood"},{"key":"301_CR39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay, S. R., Fiszbein, A. & Opler, L. A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13, 261\u2013276 (1987).","journal-title":"Schizophr. Bull."},{"key":"301_CR40","doi-asserted-by":"crossref","unstructured":"Guy W. ECDEU Assessment Manual for Psychopharmacology. (Rockville, MD, U.S. Department of Health, Education, and Welfar, 1976)","DOI":"10.1037\/e591322011-001"},{"key":"301_CR41","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1176\/ajp.149.9.1148","volume":"149","author":"HH Goldman","year":"1992","unstructured":"Goldman, H. H., Skodol, A. E. & Lave, T. R. Revising axis V for DSM-IV: a review of measures of social functioning. Am. J. Psychiatry 149, 1148\u20131156 (1992).","journal-title":"Am. J. Psychiatry"},{"key":"301_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0920-9964(90)90005-R","volume":"3","author":"D Addington","year":"1990","unstructured":"Addington, D., Addington, J. & Schissel, B. A depression rating scale for schizophrenics. Schizophr. Res. 3, 247\u2013251 (1990).","journal-title":"Schizophr. Res."},{"key":"301_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.psychres.2005.10.002","volume":"144","author":"SW Kim","year":"2006","unstructured":"Kim, S. W. et al. Diagnostic validity of assessment scales for depression in patients with schizophrenia. Psychiatry Res. 144, 57\u201363 (2006).","journal-title":"Psychiatry Res"},{"key":"301_CR44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4306\/jknpa.2015.54.2.222","volume":"54","author":"D Pai","year":"2015","unstructured":"Pai, D., Woo, J. M., Son, M. H. & Lee, C. The reliability and validity of the korean version of columbia-suicide severity rating scale in alcohol dependent patients. J. Korean Neuropsychiatr. Assoc. 54, 222\u2013227 (2015).","journal-title":"J. Korean Neuropsychiatr. Assoc."},{"key":"301_CR45","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/01.nmd.0000253783.32338.6e","volume":"195","author":"M Harrow","year":"2007","unstructured":"Harrow, M. & Jobe, T. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: A 15-year multi-followup study. J. Nerv. Ment. Dis. 195, 406\u2013414 (2007).","journal-title":"J. Nerv. Ment. Dis."},{"key":"301_CR46","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1017\/S0033291712000220","volume":"42","author":"M Harrow","year":"2012","unstructured":"Harrow, M., Jobe, T. H. & Faull, R. N. Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study. Psychol. Med. 42, 2145\u20132155 (2012).","journal-title":"Psychol. Med."},{"key":"301_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jrp.2006.02.001","volume":"41","author":"B Rammstedt","year":"2007","unstructured":"Rammstedt, B. & John, O. P. Measuring personality in one minute or less: A 10-item short version of the big five inventory in English and German. J. Res. Pers. 41, 203\u2013212 (2007).","journal-title":"J. Res. Pers."},{"key":"301_CR48","first-page":"15","volume":"17","author":"SY Kim","year":"2010","unstructured":"Kim, S. Y. et al. Standardization and Validation of Big Five Inventory-Korean Version(BFI-K) in Elders. Korean J. Biol. Psychiatry 17, 15\u201325 (2010).","journal-title":"Korean J. Biol. Psychiatry"},{"key":"301_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/cp.12082","volume":"21","author":"CD Taylor","year":"2017","unstructured":"Taylor, C. D. & Harper, S. F. Early maladaptive schema, social functioning and distress in psychosis: A preliminary investigation. Clin. Psychol. 21, 135\u2013142 (2017).","journal-title":"Clin. Psychol."},{"key":"301_CR50","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1017\/S0033291706007355","volume":"36","author":"D Fowler","year":"2006","unstructured":"Fowler, D. et al. The Brief Core Schema Scales (BCSS): psychometric properties and associations with paranoia and grandiosity in non-clinical and psychosis samples. Psychol. Med. 36, 749\u2013759 (2006).","journal-title":"Psychol. Med."},{"key":"301_CR51","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/10705500802222972","volume":"15","author":"BW Smith","year":"2008","unstructured":"Smith, B. W. et al. The brief resilience scale: assessing the ability to bounce back. Int. J. Behav. Med. 15, 194\u2013200 (2008).","journal-title":"Int. J. Behav. Med."},{"key":"301_CR52","doi-asserted-by":"publisher","first-page":"443","DOI":"10.30773\/pi.2019.04.16","volume":"16","author":"JH Kim","year":"2019","unstructured":"Kim, J. H. et al. The development of the brooding scale. Psychiatr. Investig. 16, 443\u2013449 (2019).","journal-title":"Psychiatr. Investig."},{"key":"301_CR53","doi-asserted-by":"publisher","first-page":"100070","DOI":"10.1016\/j.bbih.2020.100070","volume":"5","author":"S Teasdale","year":"2020","unstructured":"Teasdale, S., M\u00f6rkl, S. & M\u00fcller-Stierlin, A. S. Nutritional psychiatry in the treatment of psychotic disorders: Current hypotheses and research challenges. Brain Behav. Immun Health 5, 100070 (2020).","journal-title":"Brain Behav. Immun Health"},{"key":"301_CR54","doi-asserted-by":"publisher","first-page":"e2648","DOI":"10.1002\/hup.2648","volume":"33","author":"M Jhon","year":"2018","unstructured":"Jhon, M. et al. Gender-specific risk factors for low bone mineral density in patients taking antipsychotics for psychosis. Hum. Psychopharmacol. 33, e2648 (2018).","journal-title":"Hum. Psychopharmacol."},{"key":"301_CR55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/01.nmd.0000243824.84651.6c","volume":"195","author":"JD Bremner","year":"2007","unstructured":"Bremner, J. D., Bolus, R. & Mayer, E. A. Psychometric properties of the Early Trauma Inventory-Self Report. J. Nerv. Ment. Dis. 195, 211\u2013218 (2007).","journal-title":"J. Nerv. Ment. Dis."},{"key":"301_CR56","first-page":"17","volume":"9","author":"A Topor","year":"2006","unstructured":"Topor, A. et al. Others: the role of family, friends, and professionals in the recovery process. Arch. Androl. 9, 17\u201337 (2006).","journal-title":"Arch. Androl."},{"key":"301_CR57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1545-5300.1990.00095.x","volume":"29","author":"SO Edman","year":"1990","unstructured":"Edman, S. O., Cole, D. A. & Howard, G. S. Convergent and discriminant validity of FACES-III: family adaptability and cohesion. Fam. Process 29, 95\u2013103 (1990).","journal-title":"Fam. Process"},{"key":"301_CR58","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.psychres.2018.06.001","volume":"267","author":"B Lambden","year":"2018","unstructured":"Lambden, B., Berge, J. & Forsell, Y. Structured physical exercise and recovery from first episode psychosis in young adults, the FitForLife study. Psychiatr. Res. 267, 346\u2013353 (2018).","journal-title":"Psychiatr. Res."},{"key":"301_CR59","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1249\/00005768-199012000-00021","volume":"22","author":"AS Jackson","year":"1990","unstructured":"Jackson, A. S. et al. Prediction of functional aerobic capacity without exercise testing. Med. Sci. Sports Exerc. 22, 863\u2013870 (1990).","journal-title":"Med. Sci. Sports Exerc."},{"key":"301_CR60","first-page":"221","volume":"18","author":"SW Kim","year":"2007","unstructured":"Kim, S. W. et al. A validation study of the Korean version of the subjective well-being under neuroleptic treatment scale-short form. Korean J. Psychopharmacol. 18, 221\u2013230 (2007).","journal-title":"Korean J. Psychopharmacol."},{"key":"301_CR61","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0920-9964(00)00166-3","volume":"50","author":"D Naber","year":"2001","unstructured":"Naber, D. et al. Improvement of schizophrenic patients\u2019 subjective well-being under atypical antipsychotic drugs. Schizophr. Res. 50, 79\u201388 (2001).","journal-title":"Schizophr. Res."},{"key":"301_CR62","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","volume":"162","author":"NC Andreasen","year":"2005","unstructured":"Andreasen, N. C. et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am. J. Psychiatry 162, 441\u2013449 (2005).","journal-title":"Am. J. Psychiatry"},{"key":"301_CR63","doi-asserted-by":"publisher","first-page":"716","DOI":"10.4088\/JCP.08m04846yel","volume":"71","author":"LP Henry","year":"2010","unstructured":"Henry, L. P. et al. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission. J. Clin. Psychiatr. 71, 716\u2013728 (2010).","journal-title":"J. Clin. Psychiatr."},{"key":"301_CR64","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4306\/pi.2017.14.1.93","volume":"14","author":"SW Kim","year":"2017","unstructured":"Kim, S. W. et al. Design and methodology of the Korean early psychosis cohort study. Psychiatry Investig 14, 93\u201399 (2017).","journal-title":"Psychiatry Investig"},{"key":"301_CR65","doi-asserted-by":"publisher","first-page":"375","DOI":"10.4088\/JCP.v66n0315","volume":"66","author":"E Lauronen","year":"2005","unstructured":"Lauronen, E. et al. Recovery from schizophrenic psychoses within the northern Finland 1966 Birth Cohort. J. Clin. Psychiatry 66, 375\u2013383 (2005).","journal-title":"J. Clin. Psychiatry"},{"key":"301_CR66","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1056\/NEJMoa002028","volume":"346","author":"JG Csernansky","year":"2002","unstructured":"Csernansky, J. G., Mahmoud, R. & Brenner, R., Risperidone-USA-79 Study Group. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N. Engl. J. Med. 346, 16\u201322 (2002).","journal-title":"N. Engl. J. Med."},{"key":"301_CR67","doi-asserted-by":"publisher","unstructured":"Li, L. et al. Comparison of clinical features and 1-year outcomes between patients with psychotic disorder not otherwise specified and those with schizophrenia. Early Interv. Psychiatry. https:\/\/doi.org\/10.1111\/eip.13276 (2022).","DOI":"10.1111\/eip.13276"},{"key":"301_CR68","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00005053-199504000-00004","volume":"183","author":"S Fennig","year":"1995","unstructured":"Fennig, S. et al. Psychotic patients with unclear diagnoses: A descriptive analysis. J. Nerv. Mental Dis. 183, 207\u2013213 (1995).","journal-title":"J. Nerv. Mental Dis."},{"key":"301_CR69","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1176\/appi.ps.201200570","volume":"65","author":"R Doyle","year":"2014","unstructured":"Doyle, R. et al. First-episode psychosis and disengagement from treatment: a systematic review. Psychiatr. Serv. 65, 603\u2013611 (2014).","journal-title":"Psychiatr. Serv"},{"key":"301_CR70","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","volume":"56","author":"D Robinson","year":"1999","unstructured":"Robinson, D. et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch. Gen. Psychiatry 56, 241\u2013247 (1999).","journal-title":"Arch. Gen. Psychiatry"},{"key":"301_CR71","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1176\/appi.ps.201400316","volume":"67","author":"D Berg\u00e9","year":"2016","unstructured":"Berg\u00e9, D. et al. Predictors of relapse and functioning in first-episode psychosis: a two-year follow-up study. Psychiatr. Serv 67, 227\u2013233 (2016).","journal-title":"Psychiatr. Serv"},{"key":"301_CR72","doi-asserted-by":"crossref","unstructured":"Pelayo-Ter\u00e1n, J. M. et al. Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP). Eur Arch. Psychiatry Clin. Neurosci. 267, 315\u2013323 (2017).","DOI":"10.1007\/s00406-016-0740-3"},{"key":"301_CR73","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/hup.571","volume":"19","author":"K Sim","year":"2004","unstructured":"Sim, K. et al. Depot antipsychotic use in schizophrenia: an East Asian perspective. Hum. Psychopharmacol 19, 103\u2013109 (2004).","journal-title":"Hum. Psychopharmacol"},{"key":"301_CR74","first-page":"67","volume":"15","author":"G Kang","year":"2010","unstructured":"Kang, G., Kang, S., Yoon, H. & Lee, J. Attitudes of patients with schizophrenia and their caretakers toward treatment with long-acting injectable antipsychotic medication. J. Korean Assoc. Soc. Psychiatry 15, 67\u201373 (2010).","journal-title":"J. Korean Assoc. Soc. Psychiatry"},{"key":"301_CR75","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/eip.12262","volume":"11","author":"SU Yeo","year":"2017","unstructured":"Yeo, S. U. et al. Acceptance rate of long-acting injection after short information: a survey in patients with first- and multiple-episode psychoses and their caregivers. Early Interv. Psychiatry 11, 509\u2013516 (2017).","journal-title":"Early Interv. Psychiatry"},{"key":"301_CR76","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.4088\/JCP.v67n1216","volume":"67","author":"S Heres","year":"2006","unstructured":"Heres, S., Hamann, J., Kissling, W. & Leucht, S. Attitudes of psychiatrists toward antipsychotic depot medication. J. Clin. Psychiatry 67, 1948\u20131953 (2006).","journal-title":"J. Clin. Psychiatry"},{"key":"301_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2014.07.005","volume":"159","author":"M Marshall","year":"2014","unstructured":"Marshall, M. et al. Impact of early intervention services on duration of untreated psychosis: data from the National EDEN prospective cohort study. Schizophr. Res. 159, 1\u20136 (2014).","journal-title":"Schizophr. Res."},{"key":"301_CR78","doi-asserted-by":"publisher","first-page":"e000190","DOI":"10.1136\/bmjoq-2017-000190","volume":"7","author":"K Singh","year":"2018","unstructured":"Singh, K., Ghazi, F., White, R., Sarfo-Adu, B. & Carter, P. Improving access to Early Intervention in Psychosis (EIP): the 2-week wait for cancer comes to psychosis. BMJ Open. Qual. 7, e000190 (2018).","journal-title":"BMJ Open. Qual."},{"key":"301_CR79","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/papt.12337","volume":"94","author":"Z Boden-Stuart","year":"2021","unstructured":"Boden-Stuart, Z., Larkin, M. & Harrop, C. Young adults\u2019 dynamic relationships with their families in early psychosis: Identifying relational strengths and supporting relational agency. Psychol. Psychother. 94, 646\u2013666 (2021).","journal-title":"Psychol. Psychother."},{"key":"301_CR80","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s40501-017-0112-2","volume":"4","author":"VA Mittal","year":"2017","unstructured":"Mittal, V. A. et al. Exercise treatments for psychosis: a review. Curr. Treat Options Psychiatry 4, 152\u2013166 (2017).","journal-title":"Curr. Treat Options Psychiatry"}],"container-title":["Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41537-022-00301-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-022-00301-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-022-00301-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T06:08:35Z","timestamp":1667110115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41537-022-00301-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["301"],"URL":"https:\/\/doi.org\/10.1038\/s41537-022-00301-4","relation":{},"ISSN":["2754-6993"],"issn-type":[{"value":"2754-6993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"assertion":[{"value":"25 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}